NOX4 and cardiac hypertrophy: A more targeted approach to NOX4 inhibition has shown promise in preclinical models of cardiac hypertrophy: a strategy using cell-derived vesicles (CEVs) loaded with small interfering RNA targeting NOX4 (siNOX4) was developed [106].